Israel Englander Zentalis Pharmaceuticals, Inc. Put Options Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ZNTL
# of Institutions
140Shares Held
59.1MCall Options Held
7.9KPut Options Held
42.5K-
Matrix Capital Management Company, LP Waltham, MA14MShares$17.6 Million6.94% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$6.07 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$4.11 Million0.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC2.1MShares$2.65 Million23.31% of portfolio
-
Decheng Capital LLC Menlo Park, CA2.02MShares$2.54 Million0.9% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $71.8M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...